Keyphrases
Tumor
100%
Pituitary Tumor
100%
GH Replacement Therapy
100%
Radiotherapy
75%
GH Deficiency
75%
Tumor Recurrence
75%
GH Treatment
75%
Progression Rate
50%
GH Secretion
25%
Non-associated
25%
Multivariate Analysis
25%
Tumor Progression
25%
Replacement Treatment
25%
Long Follow-up
25%
Previous History
25%
Neurosurgery
25%
Residual Disease
25%
Long-term Safety
25%
Risk of Progression
25%
Retrospective Analysis
25%
Recurrence Risk
25%
Residual Tumor
25%
Recurrence Prediction
25%
Patient with Tumor
25%
Neoplasm Recurrence
25%
Tumor Enlargement
25%
Multiple Covariates
25%
Medicine and Dentistry
Neoplasm
100%
Substitution Therapy
100%
Pituitary Tumour
100%
Recurrent Disease
37%
Growth Hormone Deficiency
37%
Tumor Recurrence
25%
Radiation Therapy
25%
Tumor Progression
12%
Growth Hormone Release
12%
Multivariate Analysis
12%
Recurrence Risk
12%
Neurosurgery
12%
Minimal Residual Disease
12%
Patient History of Radiotherapy
12%
Nursing and Health Professions
Neoplasm
100%
Substitution Therapy
100%
Hypophysis Tumor
100%
Growth Hormone Deficiency
37%
Recurrent Disease
37%
Tumor Recurrence
25%
Radiotherapy
25%
Multivariate Analysis
12%
Neurosurgery
12%
Minimal Residual Disease
12%
Tumor Growth
12%
Recurrence Risk
12%
Patient History of Radiotherapy
12%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Replacement Therapy
100%
Hypophysis Tumor
100%
Recurrent Disease
37%
Growth Hormone Deficiency
37%
Tumor Recurrence
25%
Minimal Residual Disease
12%
Tumor Growth
12%
Patient History of Radiotherapy
12%
Recurrence Risk
12%
Immunology and Microbiology
Growth Hormone Release
100%